Complete Guide to Entresto (Sacubitril/Valsartan) Pharmacokinetics
Overview
Entresto (Sacubitril/Valsartan) is a Small Molecule used in the Cardiology therapeutic area. It is indicated for Heart failure with reduced ejection fraction. Simulate Entresto (sacubitril/valsartan) pharmacokinetics. This PK simulator models the neprilysin inhibitor and angiotensin receptor blocker combination for heart failure.
Mechanism of Action
Entresto (Sacubitril/Valsartan) exerts its pharmacological effect by targeting Neprilysin/AT1R. As a Small Molecule, it modulates this target to achieve therapeutic efficacy in Heart failure with reduced ejection fraction. Understanding the target engagement is critical for interpreting the pharmacokinetic-pharmacodynamic (PK/PD) relationship and optimizing dosing regimens.
Key Pharmacokinetic Parameters
This 2-CMT PopPK model for Entresto (Sacubitril/Valsartan) characterizes the time-course of drug concentrations following Oral administration. Key parameters such as clearance (CL), volume of distribution (Vd), and absorption rate constant (Ka) define the drug's disposition. Use the interactive simulator below to explore these parameters in detail.
Dosing & Administration
Entresto (Sacubitril/Valsartan) is administered via the Oral route. Oral administration involves absorption from the gastrointestinal tract, and bioavailability may be affected by food intake, formulation, and first-pass metabolism.
Dosing recommendations should always follow approved prescribing information. The interactive simulator allows you to explore different dosing scenarios and their impact on drug exposure metrics such as AUC, Cmax, and Ctrough.
Clinical Considerations
In the Cardiology therapeutic area, for the treatment of Heart failure with reduced ejection fraction, understanding the pharmacokinetics of Entresto (Sacubitril/Valsartan) is essential for dose optimization and therapeutic drug monitoring. Key clinical factors that may affect Entresto (Sacubitril/Valsartan) pharmacokinetics include:
- •Body weight and body composition
- •Renal and hepatic function
- •Drug-drug interactions and concomitant medications
- •Age, sex, and genetic polymorphisms
Interactive Entresto (Sacubitril/Valsartan) PK Simulator
Explore Entresto (Sacubitril/Valsartan) pharmacokinetics interactively. Adjust doses, dosing intervals, and patient covariates to visualize concentration-time profiles in real time.
Frequently Asked Questions
What is the half-life of Entresto (Sacubitril/Valsartan)?
The elimination half-life of Entresto (Sacubitril/Valsartan) depends on patient-specific factors. Use our interactive Entresto (Sacubitril/Valsartan) PK simulator to explore concentration-time profiles and estimate half-life under different dosing scenarios.
How is Entresto (Sacubitril/Valsartan) administered?
Entresto (Sacubitril/Valsartan) is administered via the Oral route. It is indicated for Heart failure with reduced ejection fraction. As a Small Molecule, dosing regimens should follow approved prescribing information and clinical guidelines.
What are the key PK parameters of Entresto (Sacubitril/Valsartan)?
Key pharmacokinetic parameters for Entresto (Sacubitril/Valsartan) include clearance (CL), volume of distribution (Vd), and elimination half-life. Our interactive simulator uses a 2-CMT PopPK model to characterize the pharmacokinetics of Entresto (Sacubitril/Valsartan).
Can I simulate Entresto (Sacubitril/Valsartan) dosing scenarios for free?
Yes! PKPDBuilder offers a completely free, interactive Entresto (Sacubitril/Valsartan) PK simulator based on published pharmacometric models. No login required. Use it to explore different doses, dosing intervals, and patient covariates.
⚠️ Disclaimer
This guide is for research and educational purposes only. It is not intended for clinical decision-making or patient dosing. Parameters are derived from published literature and represent population estimates. Always consult approved prescribing information for clinical use.